Clinical Trial Update: Omega-3 Fatty Acids For Treatment Of Young Children With Autism (OMG) [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating omega-3 fatty acids for autism in young children (OMG). Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Holland Bloorview Kids Rehabilitation Hospital | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED | Results posted: 2016-05-18